- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04150094
Intravaginal Vibratory Stimulus and Pelvic Floor Muscle Training
September 21, 2023 updated by: Hospital de Clinicas de Porto Alegre
Intravaginal Vibratory Stimulus and Pelvic Floor Muscle Training to Treat Female Urinary Incontinence: a Randomized Clinical Trial
This is a randomized blinded trial with non-probabilistic sampling for convenience.
Our goal is to compare PFMT with intravaginal vibratory stimulus versus PFMT alone on the treatment of female urinary incontinence.
Study Overview
Status
Withdrawn
Conditions
Detailed Description
This is a randomized blinded trial with non-probabilistic sampling for convenience.
Our goal is to compare PFMT with intravaginal vibratory stimulus versus PFMT alone on the treatment of female urinary incontinence.
Women with an indication for conservative treatment of urinary incontinence will be referred to the Pelvic Floor Physiotherapy Team by the Medical Team of the Ambulatory of Urogynecology and Obstetrics of the Hospital de Clínicas de Porto Alegre and those who are in compliance with the inclusion criteria proposed for the research will be invited to participate in the study.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
RS
-
Porto Alegre, RS, Brazil, 90035-903
- José Geraldo Lopes Ramos
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Women with urinary incontinence;
- Know how to perform a voluntary pelvic floor muscle contraction;
- Have not undergone pelvic floor muscle training in the last 6 months;
- Understand the instruments used in research.
Exclusion Criteria:
- Latex allergy;
- Neurological diseases;
- Pelvic organ prolapse > grade 2;
- Pain during vaginal palpation and / or introduction of the vaginal probe;
- Vaginal atrophy;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Pelvic floor muscle training (PFMT)
Pelvic floor muscle training without stimulus.
|
Participants will be firstly evaluated and orientated about pelvic floor muscles and pelvic floor muscle training.
They will be clarified about the role of pelvic floor muscles in continence mechanisms and will be orientated to perform 8 weeks of PFMT without stimulus, coming once a week to a session supervised by physiotherapist and will be encouraged to perform the exercises at home during the other week days.
|
Experimental: Pelvic floor muscle training + intravaginal vibratory stimulus
Pelvic floor muscle training with intravaginal vibratory stimulation.
|
Participants will be firstly evaluated and orientated about pelvic floor muscles and pelvic floor muscle training.
They will be clarified about the role of pelvic floor muscles in continence mechanisms and will be orientated to perform 8 weeks of PFMT with intravaginal vibratory stimulus.
They will need to come once a week to a session supervised by physiotherapist to use the vibration device and will be encouraged to perform the exercises at home during the other week days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in urinary incontinence
Time Frame: 8 weeks
|
We will measure it using the "International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF) - Portuguese version", pre and post treatment, to assess if there are any changes in bladder control after the protocols.
It consists of 3 scored items which evaluate the frequency, volume of leakage and overall impact of incontinence.
The overall score ranges from 0 to 21, with greater values indicating increased severity.
Klovning et al (2009) says that ICIQ-SF may be divided into the following four severity categories of UI: slight (1-5), moderate (6-12), severe (13-18) and very severe (19-21).
Lim et al (2019) suggested that for women undergoing nonsurgical treatments for incontinence, reductions of 4 points in ICIQ-UI SF are perceived as clinically meaningful.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Impact in quality of life
Time Frame: 8 weeks
|
We are using the "International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF) - Portuguese version", which asks about overall impact of UI in quality of life by a scale from 0-10 of how much these symptoms bothered the patient's life.
We are going to say the participant "imagine that 0 is if urinary leakage doesn't bother you at all and 10 is as much as this can disrupt your life".
There are other questions in this questionnaire according to the severity of the UI symptoms.
Each answer has a punctuation and the total score could range between 0 and 21.
The higher, the worse is the severity of UI and the impact on the participant's quality of life.
The ICIQ is highly recommended (Grade A) for the basic evaluation of the patient's perspective of urinary incontinence (Abrams et al, 2010).
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jose Geraldo Lopes Ramos, Hospital de Clinicas de Porto Alegre
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 10, 2019
Primary Completion (Estimated)
December 20, 2021
Study Completion (Estimated)
December 20, 2021
Study Registration Dates
First Submitted
October 31, 2019
First Submitted That Met QC Criteria
October 31, 2019
First Posted (Actual)
November 4, 2019
Study Record Updates
Last Update Posted (Actual)
September 22, 2023
Last Update Submitted That Met QC Criteria
September 21, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Behavioral Symptoms
- Mental Disorders
- Urologic Diseases
- Lower Urinary Tract Symptoms
- Urological Manifestations
- Urination Disorders
- Elimination Disorders
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Male Urogenital Diseases
- Urinary Incontinence
- Enuresis
Other Study ID Numbers
- 2018-0354
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
The SPSS spreadsheet with relevant research data (characterization of the sample and severity of UI) and statistical analysis may be shared by e-mail request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Incontinence
-
University of New MexicoRecruitingUrinary Incontinence | Urge Incontinence | Stress Incontinence, FemaleUnited States
-
Juna d.o.o.CompletedFemale Stress Urinary Incontinence | Mixed Incontinence, Urge and Stress
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...CompletedUrinary Incontinence, Stress | Urge Incontinence | Urinary Stress Incontinence | Stress Incontinence, Urinary | Stress Incontinence | Stress Incontinence, Female | Urgency UrinaryUnited States
-
Ludwig-Maximilians - University of MunichUnknownIncontinence, Overactive Bladder, Stress Urinary IncontinenceGermany
-
Far Eastern Memorial HospitalRecruitingWomen With Stress Urinary IncontinenceTaiwan
-
Université de SherbrookeRecruitingUrinary Incontinence | Urinary Stress Incontinence | Post-Prostatectomy Incontinence | Stress Incontinence, MaleCanada
-
University of ZurichCompletedStress Urinary Incontinence | Urge Urinary Incontinence
-
Northwestern UniversityFriends of PrenticeCompletedStress Urinary Incontinence | Mixed Urinary Incontinence | Urgency IncontinenceUnited States
-
Hadassah Medical OrganizationCompletedUrinary Stress Incontinence (SI)Israel
-
San Diego Sexual MedicineRecruitingStress Urinary Incontinence | Urge IncontinenceUnited States
Clinical Trials on Pelvic floor muscle training (PFMT)
-
Pavol Jozef Safarik UniversityCompletedStress Urinary IncontinenceSlovakia
-
Glasgow Caledonian UniversityNHS Greater Glasgow and ClydeCompletedPelvic Organ ProlapseUnited Kingdom
-
University Hospital Plymouth NHS TrustCompletedBehaviouralUnited Kingdom
-
Giresun UniversityCompletedUrinary Incontinence | Urinary Incontinence, Stress | Pelvic Floor Disorders | Electrical StimulationTurkey
-
Chulalongkorn UniversityCompletedUrinary Incontinence
-
Hadassah Medical OrganizationWithdrawnQuality of Life | Stress Urinary Incontinence | Sexual SatisfactionIsrael
-
Yuan-Mei Liao, RN, PhDNot yet recruitingQuality of Life | Genitourinary Symptoms | Sexual Function
-
University of Trás-os-Montes and Alto DouroUnknown
-
Norwegian School of Sport SciencesThe Research Council of Norway; University Hospital, AkershusCompletedUrinary IncontinenceNorway
-
The Hong Kong Polytechnic UniversityNot yet recruitingStress Urinary IncontinenceHong Kong